What Are Prostaglandins and How They Function in the Body

What Are Prostaglandins and How the Body Produces Them

Cells synthesize prostaglandins directly from structural fats stored in their outer membranes. Production starts fast. Phospholipase A2 enzymes release arachidonic acid from membrane phospholipids, allowing cyclooxygenase (COX) enzymes to convert it into prostaglandin H2 (PGH2), an unstable intermediate compound.

Specific tissue enzymes convert PGH2 into distinct prostanoids according to local functional requirements. These final molecules include prostaglandin E2 (PGE2), prostacyclin (PGI2), prostaglandin D2 (PGD2), prostaglandin F2-alpha (PGF2α), and thromboxane A2 (TXA2). According to StatPearls (NCBI Bookshelf), each prostanoid executes its effects through a dedicated class of cell-surface receptor proteins.

Receptor targeting remains precise across tissues. Prostaglandin D2 binds to DP receptors, PGE2 binds to EP receptors, PGF2α activates FP receptors, and TXA2 acts on TP receptors. Prostaglandins act locally, at or near their site of synthesis, rather than traveling to distant tissues, as noted by StatPearls (NCBI Bookshelf).

Cyclooxygenase Enzymes COX-1 and COX-2

Two related cyclooxygenase enzymes, known as COX-1 and COX-2, catalyze the conversion of arachidonic acid into prostanoid precursors. They serve different purposes. While COX-1 maintains continuous baseline physiology, COX-2 activates during injury to coordinate inflammatory defense.

Cells express COX-1 continuously. This baseline enzyme produces prostaglandins that regulate kidney blood flow and assist platelet aggregation for normal clotting. In the stomach, COX-1 activity stimulates protective mucus and bicarbonate secretion to shield the lining from acidic digestive juices.

In contrast, tissues express COX-2 primarily when provoked by inflammatory signals. Cytokines, growth factors, and mechanical strain rapidly induce COX-2 synthesis. This inducible pathway drives the elevated prostaglandin production responsible for inflammatory swelling and pain, as detailed in StatPearls (NCBI Bookshelf).

Major Functions of Prostaglandins Across the Body

Prostaglandins regulate cardiovascular dynamics, gastrointestinal protection, immune activation, and smooth muscle tone throughout human organ systems. Their actions depend on tissue location. Because different tissues express distinct prostanoid synthases and receptors, these lipids execute specialized tasks across the body as outlined by the Cleveland Clinic.

Cardiovascular function requires balance. Endothelial cells lining blood vessels produce prostacyclin (PGI2), a vasodilator and the most potent natural inhibitor of platelet aggregation in most mammals. Platelets produce thromboxane A2 (TXA2), which drives vasoconstriction and platelet clumping, as explained in StatPearls (NCBI Bookshelf).

During infection or physical trauma, prostaglandin E2 acts as a primary mediator of inflammatory pain and fever. It acts on the central nervous system. Among its roles, PGE2 is a primary mediator of fever and pain sensitization during infection or physical trauma.

Prostaglandins also maintain gastrointestinal (GI) mucosal integrity and modulate smooth muscle contractions. They suppress gastric acid secretion while stimulating protective mucus and bicarbonate release. In the digestive and reproductive tracts, these lipids coordinate smooth muscle contraction and relaxation, while within the eye they regulate intraocular pressure dynamics.

Uterine Contractions and Menstrual Cramps

Excessive endometrial prostaglandin synthesis is the primary biological driver of pain in women experiencing primary dysmenorrhea. Cramps originate in the endometrium. Women with primary dysmenorrhea produce elevated levels of prostaglandin F2-alpha (PGF2α) and prostaglandin E2 (PGE2) in the uterine lining prior to menstruation.

When the endometrial lining sheds, these accumulated prostaglandins spill into menstrual fluid in abnormally high concentrations. This chemical surge causes uterine smooth muscle hyperactivity. Severe contractions constrict local blood vessels, reducing blood flow and oxygen delivery to the myometrium, which triggers acute cramping pain.

Suppression of these lipids directly relieves menstrual symptoms. Clinical evidence from a Cochrane review on PubMed demonstrates that nonsteroidal anti-inflammatory drugs inhibit cyclooxygenase enzymes, reducing menstrual prostaglandin release back to normal levels. Hormonal factors also play a role, as outlined in our estrogen dominance guide, where elevated estrogen promotes excess prostaglandin production and intensifies menstrual cramping.

How Nonsteroidal Anti-Inflammatory Drugs Inhibit Prostaglandins

Nonsteroidal anti-inflammatory drugs relieve fever, swelling, and pain by directly inhibiting cyclooxygenase enzymes to stop prostaglandin synthesis. Over-the-counter options include ibuprofen, naproxen, and aspirin. By blocking COX enzymes, these medications halt the production of downstream inflammatory prostaglandins, which accounts for both their therapeutic benefits and their side effects as explained by the Cleveland Clinic.

Stomach irritation represents the most frequent adverse effect of nonselective COX inhibitors. Because drugs like ibuprofen inhibit COX-1 along with COX-2, they diminish protective prostaglandins in the gastric mucosa. Without sufficient prostaglandins to stimulate mucus and bicarbonate secretion, gastric acid can erode the stomach lining, increasing the risk of mucosal irritation and ulcers.

Synthetic prostaglandins can counteract this gastric vulnerability. The pharmaceutical compound misoprostol, a synthetic prostaglandin E1 (PGE1) analog, directly inhibits gastric acid secretion while stimulating protective mucus and bicarbonate production in the stomach wall. Physicians prescribe this analog specifically to prevent NSAID-induced mucosal ulceration in patients requiring ongoing anti-inflammatory therapy.

Dosage and enzyme selectivity alter cardiovascular outcomes. Low-dose aspirin (such as 81 mg) inhibits platelet thromboxane A2 far more than endothelial prostacyclin, creating a heart-protective antiplatelet effect. Conversely, selective COX-2 inhibitors suppress protective PGI2 while leaving COX-1-driven thromboxane intact, tilting the balance toward clotting and prompting cardiovascular warnings, as noted in StatPearls (NCBI Bookshelf).

Therapeutic Prostaglandin Analogs in Clinical Medicine

Synthetic prostaglandin analogs serve as prescription medications across ophthalmology, obstetrics, and gastroenterology. These drugs mimic natural prostanoids to produce a targeted clinical effect.

In eye care, synthetic prostaglandin F2-alpha (PGF2α) analogs lower intraocular pressure in patients with glaucoma. Prescription eye drops including latanoprost, bimatoprost, travoprost, tafluprost, and latanoprostene bunod enhance uveoscleral outflow, allowing excess fluid to exit the eye. Additionally, bimatoprost is approved to promote eyelash growth through local follicle stimulation.

Obstetric medicine uses prostanoid analogs extensively. Dinoprostone, a synthetic PGE2 analog, facilitates cervical ripening and labor induction, while misoprostol provides an off-label alternative for induction protocols. To control postpartum hemorrhage or induce abortion, clinicians administer carboprost, a synthetic PGF2α analog that triggers intense uterine contractions, as cataloged in StatPearls (NCBI Bookshelf).

Metabolic Context and Related Inflammatory Signaling

Nutritional fats and cellular peptides directly influence the baseline production of inflammatory prostaglandins throughout human tissue. Diet modifies cellular membranes. As covered in our overview of omega-3 and joint inflammation, regular consumption of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) reduces joint discomfort partly by suppressing inflammatory prostaglandin E2 synthesis.

When omega-3 fatty acids displace arachidonic acid within phospholipid membranes, downstream inflammatory signaling drops substantially. Experimental peptide science shows similar regulatory interactions. As discussed in our review of BPC-157, animal research indicates this peptide modulates prostaglandin production, nitric oxide synthesis, and inflammatory cytokine cascades to reduce tissue injury.

Hormonal balance, dietary fats, and medication choices all converge on these local tissue cascades. Persistent pain warrants clinical evaluation. If you struggle with recurring joint pain or severe menstrual cramps, consulting a physician represents the best step to determine whether elevated prostaglandins are driving your symptoms.